The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Latest Share Chat

Futura Medical Share News (FUM)

Futura Medical Information

Buy FUM Shares
Add FUM to Watchlist
Add FUM to Alert

Share Price Information for Futura Medical (FUM)

London Stock Exchange

Share Price is delayed by 15 minutes

Share Price: 41.30

Bid: 0.00

Ask: 60.00

Change: 0.00 (0.00%)

Spread: 19.85 (49.44%)

Open: 0.00

High: 0.00

Low: 0.00

Prev. Close: 41.30

FUM Live Price

Last checked at -

IN BRIEF: Futura Medical's Eroxon to soon be available on prescription

Wed, 14th Feb 2024 09:24

Futura Medical PLC - Guildford, England-based pharmaceutical company focused on sexual health products - Confirms that lead product Eroxon will from March 1 be available on prescription in England and Wales for the treatment of erectile dysfunction. Eroxon is a gel-based treatment designed to help the user obtain an erection, and serves as an alternative for people who are unwilling or unable to use medications like Viagra. Eroxon has also been available without a prescription in UK pharmacies since March last year.

Current stock price: 41.00 pence, up 6.5% on Wednesday morning

12-month change: 27%

By Emma Curzon, Alliance News reporter

Comments and questions to newsroom@alliancenews.com

Copyright 2024 Alliance News Ltd. All Rights Reserved.

More News

28 Jun 2021 19:35

TRADING UPDATES: Anglo-Eastern tips palm oil price fall; DX expands

TRADING UPDATES: Anglo-Eastern tips palm oil price fall; DX expands

28 Jun 2021 10:02

Futura Medical makes progress with topical erection gel

(Sharecast News) - Pharmaceutical company Futura Medical updated the market on its topical erectile dysfunction (ED) treatment 'MED3000' on Monday, given it now had CE-mark approval in Europe for the treatment of ED in adult men.

4 Jun 2021 09:36

BROKER RATINGS: Morgan Stanley upgrades boohoo to Equal Weight

BROKER RATINGS: Morgan Stanley upgrades boohoo to Equal Weight

3 Jun 2021 12:50

Thursday broker round-up

(Sharecast News) - Experian: RBC Capital Markets downgrades to underperform with a target price of 2,400p.

26 May 2021 16:04

UK shareholder meetings calendar - next 7 days

UK shareholder meetings calendar - next 7 days

17 May 2021 15:04

TRADING UPDATES: Pelatro gets contracts; Futura raises GBP10 million

TRADING UPDATES: Pelatro gets contracts; Futura raises GBP10 million

14 May 2021 17:20

IN BRIEF: Futura Medical to raise GBP12 million to fund clinical study

IN BRIEF: Futura Medical to raise GBP12 million to fund clinical study

7 May 2021 15:54

UK earnings, trading statements calendar - next 7 days

UK earnings, trading statements calendar - next 7 days

30 Apr 2021 13:23

Futura Medical surges on EU approval for topical erection gel

(Sharecast News) - Pharmaceutical company Futura Medical has received CE marking for its 'MED3000' erectile dysfunction gel, it announced on Friday.

30 Apr 2021 11:32

Futura wins EU approval for "breakthrough" erectile dysfunction gel

Futura wins EU approval for "breakthrough" erectile dysfunction gel

30 Apr 2021 10:40

AIM WINNERS & LOSERS: Hurricane Energy warns of "significant dilution"

AIM WINNERS & LOSERS: Hurricane Energy warns of "significant dilution"

15 Apr 2021 19:37

TRADING UPDATES: HSBC announces redemption of US dollar securities

TRADING UPDATES: HSBC announces redemption of US dollar securities

14 Apr 2021 12:04

TRADING UPDATES: Quixant swings to 2020 loss but recommends dividend

TRADING UPDATES: Quixant swings to 2020 loss but recommends dividend

22 Mar 2021 11:22

AIM WINNERS & LOSERS: Futura Medical shares rise on US FDA agreement

AIM WINNERS & LOSERS: Futura Medical shares rise on US FDA agreement

22 Mar 2021 09:43

Futura Medical shares rise on FDA's agreement for MED3000 study

Futura Medical shares rise on FDA's agreement for MED3000 study